Changes in directorships
Changes in directorships
There were also changes in directorships.
At the level of Linetrust PTC, Mr Fokin was the sole director until 18 March 2022. For some months thereafter the directors were Ms Skittides and Mr Constantinides. Ms Skittides was educated at Moscow State University before qualifying to practise as a lawyer in Cyprus. She is a professional trustee and corporate service provider and has worked for and with various significant Russian/CIS corporations, including Cargotrans and several Russian banks.
Mr Noble was appointed as director of Linetrust PTC on 10 June 2022. Mr Lillikas was appointed on 28 June 2022. At some point (I do not know the date), Mr Constantinides resigned. Mr Lillikas was previously a politician in Cyprus. In that capacity, he was well-known to be pro-Russian, arguing publicly that Cyprus should not enforce EU sanctions against Russia and that Cyprus should allow Russia a military base on the island.
As already noted, Mr Fokin was a director of Linea until 18 March 2022, and a director of AIM Capital until 22 January 2024.
At the level of EuroChem AG, Mr Samir Brikho, who had been Chairman of EuroChem AG and the CEO of the EuroChem Group, resigned. So did Mr Vladimir Rashevsky, who had also been CEO, but was himself added to the list at Annex I to Regulation 269 on 15 March 2022. Mr Hechler assumed the position of CEO in June 2024 and became a director in October 2024.
I am not aware of any relevant changes at the levels of MCC EuroChem or EuroChem NW2. At some point, Mr Shiryaev was succeeded by Mr Vanyushin as the person with the head title at MCC EuroChem, but I do not know precisely when or why this occurred. I have no reason to suppose that this change related to sanctions.
- Heading
- PART A: INTRODUCTION AND PARTIES [1]-[22]
- II: The Claimants [11]-[17]
- III: The Banks and Tecnimont [18]-[20]
- IV: The new Kingisepp plant [21]-[22]
- PART B: THE BONDS AND EUROCHEM NW2’S DEMANDS [23]-[45]
- VI: Designation under Regulation 269 [29]-[33]
- VII: Termination of the Contracts [34]-[37]
- VIII: EuroChem NW2’s demands on the Bonds [38]-[40]
- IX: Rejection of the demands [41]-[45]
- PART C: THE ISSUES AND THE WITNESSES [46]-[98]
- XI: The Claimants’ EuroChem AG witnesses [59]-[66]
- Mr Valters and Mr Solzhenitsyn
- Mr Hechler
- Mr Collishe
- Ms Basyrova
- XII: The Claimants’ EuroChem NW2 witness [67]-[73]
- XIII: The Claimants’ Trust witnesses [74]-[94]
- Mr Fokin
- Mr Noble
- XIV: The Banks’ witnesses [95]-[98]
- PART D: THE FACTS RE OWNERSHIP AND CONTROL [99]-[211]
- The Trusts above EuroChem AG
- The structure from EuroChem AG downwards
- XVI: The ownership structure after sanctions [110]-[123]
- Changes at the level of EuroChem AG
- Changes in directorships
- XVII: Other group structural changes [124]-[144]
- The “Future of EuroChem” memorandum
- The transfers to MCC EuroChem
- The UAE trading cluster
- Changes within EuroChem AG and the EU subsidiaries
- XVIII: Mr Melnichenko’s involvement before March 2022 [145]-[151]
- XIX: The Claimants’ first pleading point [152]-[154]
- XX: The date of the Deed of Retirement [155]-[165]
- XXI: The role of Mrs Melnichenko [166]-[175]
- XXII: Mr Melnichenko’s involvement after March 2022 (1) [176]-[187]
- XXIII: The Claimants’ second pleading point [188]-[197]
- XXIV: Mr Melnichenko’s involvement after March 2022 (2) [198]-[204]
- XXV: The Assignment [205]-[211]
- PART E: REGULATION 269 [212]-[305]
- XXVII: The supplementary EU materials [220]-[225]
- XXVIII: Decisions of the CJEU [226]-[229]
- XXIX: How to interpret Regulation 269 [230]-[240]
- XXX: Article 2(1) [241]-[248]
- XXXI: Article 2(2) [249]-[259]
- XXXII: “Ownership” [260]-[278]
- XXXIII: The Claimants’ third pleading point [279]-[282]
- XXXIV: The MP Bank v Pugachev point [283]-[293]
- XXXV: “Control” [294]-[305]
- PART F: THE NCAS [306]-[347]
- XXXVII: Firewalls and the NCAs [312]-[313]
- XXXVIII: The French NCA: the DGT [314]-[326]
- XXXIX: The Italian NCA: the CSF [327]-[332]
- XL: The Swiss NCA: the SECO [333]-[337]
- XLI: The Cypriot NCA: the SEOK [338]-[341]
- XLII: The Dutch NCA: the BTI [342]-[347]
- PART G: APPLYING REGULATION 269 [348]-[411]
- XLIV: Inferences [360]-[369]
- XLV: Article 2(1) and the Bonds [370]-[378]
- XLVI: The LIA v Maud point [379]-[399]
- XLVII: Article 2(1) and the Assignment [400]
- XLVIII: Article 2(2) and payment to EuroChem NW2 [401]-[403]
- XLIX: Article 2(2) and payment to EuroChem AG [404]-[408]
- L: The pending applications to the DGT and the CSF [409]-[411]
- PART H: REGULATION 833 [412]-[473]
- LII: Are the claims “in connection with” the Contracts? [416]-[429]
- LIII: Are the claims by or on behalf of a Russian entity? [430]-[433]
- LIV: Conclusion on Regulation 833 [434]-[435]
- PART I: THE RULE IN RALLI BROTHERS [436]-[473]
- LVI: The rule in Ralli Brothers [438]-[440]
- LVII: The place of performance under the Bonds [441]-[461]
- LVIII: Licence applications and Article 7 [462]-[465]
- LIX: Public policy [466]-[470]
- LX: Implied term [471]-[472]
- LXI: Conclusion on the rule in Ralli Brothers [473]
- PART J: OTHER ARGUMENTS [474]-[494]
- LXIII: The Bonds’ expiry dates [476]-[478]
- LXIV: Validity of the Assignment [479]-[482]
- LXV: The Assignment and Article 9 [483]-[486]
- LXVI: The sanctioned Russian banks [487]-[491]
- LXVII: ING’s Part 20 claim against Tecnimont [492]-[494]
- Conclusions
![CL-2022-000456 - [2025] EWHC 1938 (Comm)](https://backend.juristeca.com/files/emisores/logo_WAai98v.png)